| Diagnostic accuracy of transcranial sonography of the substantia nigra in Parkinson’s disease: a systematic review and meta-analysis DH Li, YC He, J Liu, SD Chen Scientific reports 6 (1), 20863, 2016 | 71 | 2016 |
| Precision medicine through antisense oligonucleotide-mediated exon skipping D Li, FL Mastaglia, S Fletcher, SD Wilton Trends in pharmacological sciences 39 (11), 982-994, 2018 | 64 | 2018 |
| Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies D Li, CS McIntosh, FL Mastaglia, SD Wilton, MT Aung-Htut Translational neurodegeneration 10 (1), 16, 2021 | 54 | 2021 |
| A community-based study of risk factors for probable rapid eye movement sleep behavior disorder JF Ma, Y Qiao, X Gao, L Liang, XL Liu, DH Li, HD Tang, SD Chen Sleep medicine 30, 71-76, 2017 | 51 | 2017 |
| Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era D Li, FL Mastaglia, S Fletcher, SD Wilton Medicinal Research Reviews 40 (6), 2650-2681, 2020 | 40 | 2020 |
| Pyrimidine biosynthetic enzyme CAD: its function, regulation, and diagnostic potential G Li, D Li, T Wang, S He International Journal of Molecular Sciences 22 (19), 10253, 2021 | 38 | 2021 |
| Substantia nigra echogenicity correlated with clinical features of Parkinson's disease HY Zhou, Q Sun, YY Tan, YY Hu, WW Zhan, DH Li, Y Wang, Q Xiao, J Liu, ... Parkinsonism & related disorders 24, 28-33, 2016 | 36 | 2016 |
| Effect of a leucine-rich repeat kinase 2 variant on motor and non-motor symptoms in Chinese Parkinson’s disease patients Q Sun, T Wang, TF Jiang, P Huang, DH Li, Y Wang, Q Xiao, J Liu, ... Aging and disease 7 (3), 230, 2016 | 21 | 2016 |
| Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease D Li, L Zhang, Y Hu, X Jiang, H Zhou, Q Yang, W Kang, J Liu, SD Chen Parkinsonism & related disorders 21 (8), 923-928, 2015 | 21 | 2015 |
| Methylation status of DJ-1 in leukocyte DNA of Parkinson’s disease patients Y Tan, L Wu, D Li, X Liu, J Ding, S Chen Translational Neurodegeneration 5, 1-7, 2016 | 18 | 2016 |
| A splice intervention therapy for autosomal recessive juvenile Parkinson’s disease arising from Parkin mutations D Li, MT Aung-Htut, KA Ham, S Fletcher, SD Wilton International Journal of Molecular Sciences 21 (19), 7282, 2020 | 16 | 2020 |
| Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson’s Disease YC He, P Huang, QQ Li, Q Sun, DH Li, T Wang, JY Shen, JJ Du, SS Cui, ... Parkinson’s disease 2017 (1), 3217474, 2017 | 15 | 2017 |
| Serum insulin-like growth factor-1 in patients with De Novo, drug naive Parkinson’s disease: a meta-analysis DH Li, YC He, TJ Quinn, J Liu PLoS One 10 (12), e0144755, 2015 | 14 | 2015 |
| TMEM230 stop codon mutation is rare in parkinson’s disease and essential tremor in eastern China F Marzinzik, A Maier Mov Disord 31 (4), 538-546, 2016 | 12 | 2016 |
| Morpholino oligomer-induced dystrophin isoforms to map the functional domains in the dystrophin protein D Li, AM Adams, RD Johnsen, S Fletcher, SD Wilton Molecular Therapy-Nucleic Acids 22, 263-272, 2020 | 11 | 2020 |
| Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients C Gao, YM Chen, Q Sun, YC He, P Huang, T Wang, DH Li, L Liang, J Liu, ... Neurobiology of Aging 49, 218. e9-218. e11, 2017 | 10 | 2017 |
| Polyglutamine ataxias: our current molecular understanding and what the future holds for antisense therapies CS McIntosh, D Li, SD Wilton, MT Aung-Htut Biomedicines 9 (11), 1499, 2021 | 8 | 2021 |
| Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents J Chen, X Guo, D Li, H Tang, J Gao, W Yu, X Zhu, Z Sun, Z Huang, ... Metallomics 15 (6), mfad035, 2023 | 4 | 2023 |
| β-cyclodextrin based nano gene delivery using pharmaceutical applications to treat Wolfram syndrome PC Quintas, H Al-Salami, A Pfaff, D Li, S Koks Therapeutic delivery 13 (9), 449-462, 2022 | 4 | 2022 |
| Targeted molecular therapeutics for Parkinson's Disease: A role for antisense oligonucleotides? D Li, FL Mastaglia, WY Yau, S Chen, SD Wilton, PA Akkari Movement Disorders 37 (11), 2184-2190, 2022 | 3 | 2022 |
Steve WiltonFoundation Chair in Molecular Therapies, Murdoch University在 ccg.murdoch.edu.au 的电子邮件经过验证
